UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls

Acta psychiatrica Scandinavica, 2006-07, Vol.114 (1), p.27-35

2006

Volltextzugriff (PDF)

Needs assessed by psychiatric health care and social services in a defined cohort of clients with mental disabilities

European archives of psychiatry and clinical neuroscience, 2005-02, Vol.255 (1), p.57-64

2005

Volltextzugriff (PDF)

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates

Acta psychiatrica Scandinavica, 1987-12, Vol.76 (6), p.628-641

1987

Volltextzugriff (PDF)

Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment

Acta psychiatrica Scandinavica, 1986-08, Vol.74 (2), p.161-167

1986

Volltextzugriff (PDF)

Computed tomography of the brain in patients with acute psychosis and in healthy volunteers

Acta psychiatrica Scandinavica, 1982-06, Vol.65 (6), p.403-414

1982

Volltextzugriff (PDF)

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.75-92

1984

Volltextzugriff (PDF)

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Acta psychiatrica Scandinavica, 1989-08, Vol.80 (S352), p.30-34

1989

Volltextzugriff (PDF)

Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients

Acta psychiatrica Scandinavica, 1986-09, Vol.74 (3), p.292-301

1986

Volltextzugriff (PDF)

Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients

Acta psychiatrica Scandinavica, 1987-12, Vol.76 (6), p.642-647

1987

Volltextzugriff (PDF)

The Need of Support and Service Questionnaire (NSSQ): A brief scale to assess needs in clients with long-term mental disabilities

Nordic journal of psychiatry, 2005, Vol.59 (6), p.465-472

2005

Volltextzugriff (PDF)

Clinical Evaluation of Sulpiride in Schizophrenic Patients - A Double-blind Comparison with Chlorpromazine

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.7-30

1984

Volltextzugriff (PDF)

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.49-74

1984

Volltextzugriff (PDF)

Zuclopenthixol acetate in Viscoleo® ― a new drug formulation: an open Nordic multicentre study of zuclopenthixol acetate in Viscoleo® in patients with acute psychoses including mania and exacerbation of chronic psychoses

Acta psychiatrica Scandinavica, 1987, Vol.75 (1), p.99-107

1987

Volltextzugriff (PDF)

PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose

Acta psychiatrica Scandinavica, 1988-08, Vol.78 (2), p.234-241

1988

Volltextzugriff (PDF)

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients: Sulpiride and monoamine metabolite

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.75-92

1984

Volltextzugriff (PDF)

A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis

Acta psychiatrica Scandinavica, 1993-01, Vol.87 (1), p.48-58

1993

Volltextzugriff (PDF)

Clinical Evaluation of Sulpiride in Schizophrenic Patients ‐ A Double‐blind Comparison with Chlorpromazine: Sulpiride in schizophrenic

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.7-30

1984

Volltextzugriff (PDF)

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine: Drug concentrations in serum and CSF

Acta psychiatrica Scandinavica, 1984-01, Vol.69 (S311), p.49-74

1984

Volltextzugriff (PDF)

INCREASED CONTENT OF IMMUNOREACTIVE PROSTAGLANDIN E IN CEREBROSPINAL FLUID OF PATIENTS WITH SCHIZOPHRENIA

The Lancet (British edition), 1980-01, Vol.315 (8158), p.16-18

1980

Volltextzugriff (PDF)

Zuclopenthixol acetate in Viscoleo® - a new drug formulation

Acta psychiatrica Scandinavica, 1987-01, Vol.75 (1), p.99-107

1987

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Commentary

Acta psychiatrica Scandinavica, 2000, Vol.102 (2), p.153-155

2000

Volltextzugriff (PDF)

Clinical melperone treatment blocks D 2 ‐dopamine receptors in the human brain as determined by PET

Acta psychiatrica Scandinavica, 1989-08, Vol.80 (S352), p.30-34

1989

Volltextzugriff (PDF)

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Acta psychiatrica Scandinavica. Supplementum, 1989, Vol.352, p.30

1989

Volltextzugriff (PDF)

On the pathophysiology of schizophrenia

NORDIC JOURNAL OF PSYCHIATRY, 2003, Vol.57 (2), p.92

2003

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionPsychology & Behavioral Sciences Collection

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(30)
Tagungsberichte
(1)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Male
(18)
Female
(16)
Schizophrenia
(16)
Science & Technology
(16)
Adult
(15)
Life Sciences & Biomedicine
(15)
Psychiatry
(13)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Adolescent
(7)
Chlorpromazine
(7)
Middle Aged
(7)
Sulpiride
(7)
Psychology. Psychoanalysis. Psychiatry
(6)
Schizophrenia - Drug Therapy
(6)
Antipsychotic Agents - Therapeutic Use
(5)
Miscellaneous
(5)
Neuroleptics
(5)
Psychopathology. Psychiatry
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls

Needs assessed by psychiatric health care and social services in a defined cohort of clients with mental disabilities

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates

Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment

Computed tomography of the brain in patients with acute psychosis and in healthy volunteers

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients

Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients

The Need of Support and Service Questionnaire (NSSQ): A brief scale to assess needs in clients with long-term mental disabilities

Clinical Evaluation of Sulpiride in Schizophrenic Patients - A Double-blind Comparison with Chlorpromazine

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine

Zuclopenthixol acetate in Viscoleo® ― a new drug formulation: an open Nordic multicentre study of zuclopenthixol acetate in Viscoleo® in patients with acute psychoses including mania and exacerbation of chronic psychoses

PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients: Sulpiride and monoamine metabolite

A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis

Clinical Evaluation of Sulpiride in Schizophrenic Patients ‐ A Double‐blind Comparison with Chlorpromazine: Sulpiride in schizophrenic

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine: Drug concentrations in serum and CSF

INCREASED CONTENT OF IMMUNOREACTIVE PROSTAGLANDIN E IN CEREBROSPINAL FLUID OF PATIENTS WITH SCHIZOPHRENIA

Zuclopenthixol acetate in Viscoleo® - a new drug formulation

Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Commentary

Clinical melperone treatment blocks D 2 ‐dopamine receptors in the human brain as determined by PET

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

On the pathophysiology of schizophrenia

Aktive Filter

Suchergebnisse filtern